A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

NCT05659264 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure

Interventions

DRUG: mRNA-0184
DRUG: Placebo

Sponsor

ModernaTX, Inc.